Gonadotropin-releasing Hormone Analog: all 47 studies that test it
Page 1 of 1. Open to participants first (6), then studies with results posted, then the rest; newest registration first within each.
- Effect of GnRH Agonist in FETNot yet recruitingNCT07653282Phase 1/2
- Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular ClassificationRecruitingNCT07319429Phase 2/3
- Dual Trigger With HCG and GnRH Agonist on Thawed Modified Natural Cycle Embryo TransferNot yet recruitingNCT07269392Phase 4
- FET in AdenomyosisNot yet recruitingNCT06913075Not applicable
- Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or AdenomyosisRecruitingNCT04356664Phase 2/3
- Value of LNG-IUS as Fertility-preserving Treatment of EAH and ECRecruitingNCT03463252Phase 2/3
- A Study of Apalutamide Combined With GnRH Agonist in Participants With Androgen Receptor Positive Salivary Gland CarcinomaActive, not recruitingNCT04325828Phase 2Results posted
- Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate CancerActive, not recruitingNCT04262154Phase 2Results posted
- Follitropin Delta in Long GnRH Agonist and GnRH Antagonist Protocols (BEYOND)CompletedNCT03809429Phase 3Results posted
- A Study of GDC-0810 Single Agent or in Combination With Palbociclib and/or a Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast CancerTerminatedNCT01823835Phase 1/2Results posted
- The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate CancerCompletedNCT01790126Phase 2Results posted
- Females, Aging, Metabolism, and ExerciseCompletedNCT01712230Not applicableResults posted
- Gene Expression Profile After Gonadotropin Releasing Hormone (GnRH) Agonist Trigger of Oocyte MaturationTerminatedNCT01606709Phase 4Results posted
- Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate CancerActive, not recruitingNCT00567580Phase 3Results posted
- Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate CancerActive, not recruitingNCT00430183Phase 3Results posted
- Hormone Therapy and Radiation Therapy in Treating Patients With Prostate CancerCompletedNCT00005044Phase 3Results posted
- Gonadotropin-Releasing Hormone Agonists Benefit in Preserving the Ovarian Function in Premenopausal Breast Cancer Patients During ChemotherapyCompletedNCT07127315Not applicable
- Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate CancerActive, not recruitingNCT06369610Phase 2
- Two Different Types of Luteal Phase Support in Natural Cycle Frozen Embryo Transfer and Its Effect on Pregnancy RatesStatus unknownNCT05838105Not applicable
- Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene AlterationsActive, not recruitingNCT05498272Phase 2
- GnRH Agonist for Luteal Phase Support.Status unknownNCT05484193Not applicable
- Luteal Phase Support With Daily Administration of Gonadotropin-releasing Hormone Agonist Compared to Progesterone/Estradiol in IVF/ICSI Cycles With Ovulation Triggering With GnRH-aStatus unknownNCT05143723Phase 2
- INTREPId (INTermediate Risk Erection PreservatIon Trial)Active, not recruitingNCT04025372Phase 2
- Comparative Study Between Single Versus Dual Trigger for Poor Responders in GnRH-antagonist ICSI CyclesCompletedNCT04008966Phase 4
- Impact of Ultra-long Versus Long Down-regulation Protocol on IVF/ICSI in AdenomyosisWithdrawnNCT03940807Phase 3
- Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate CancerActive, not recruitingNCT03511196Early Phase 1
- Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic AdenocarcinomaActive, not recruitingNCT03436654Phase 2
- Aromatase Plus GnRH Analogue Versus GnRH Analog Alone in AdenomyosisActive, not recruitingNCT03421639Phase 4
- A Study of GDC-9545 Alone or in Combination With Palbociclib and/or Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Locally Advanced or Metastatic Estrogen Receptor-Positive Breast CancerActive, not recruitingNCT03332797Phase 1
- DuoStim in Cases of PGT: Comparison of Embryo Quantity and Embryonic Quality Using MitoScoreCompletedNCT03291821Not applicable
- A Study of Neoadjuvant TAK-700 and Leuprorelin Acetate Followed by Surgery Versus Surgery AloneTerminatedNCT03211052Phase 2
- Impact of Gonadotrophin Releasing Hormone Analogues on Oocyte and Embryo QualityStatus unknownNCT03139474Phase 2/3
- Combination of Gonadotropin-releasing Hormone Agonist and Human Chorionic Gonadotropin Triggered by Normal Responder in GnRH-antagonist CyclesStatus unknownNCT02862782Phase 3
- Effect of Prolonged GnRh Agonists on Results of Intracytoplasmic Sperm Injection (ICSI ) in Endometrioma PatientsCompletedNCT02737800Not applicable
- Cryopreserved-thawed Embryo Transfer With or Without Gonadotropin Releasing Hormone AgonistCompletedNCT02736032Phase 3
- Efficacy and Safety of Medication Used to Stimulate OvulationStatus unknownNCT02715336Phase 4
- Psychological Impact of Amenorrhea in Women With EndometriosisStatus unknownNCT02393482Phase 4
- IVF Treatment in Women With Immature Oocytes in Previous CycleCompletedNCT02368964Not applicable
- LH Response to GnRH Test in Prepubescent Girls Under 6 YearsStatus unknownNCT01944488Not applicable
- Preimplantation Genetic Diagnosis (PGD) With Gonadotropin-releasing Hormone (GnRH) Agonist Versus AntagonistCompletedNCT01888744Phase 4
- The Results of Preimplantation Genetic Diagnosis and Preimplantation Genetic Screening of Embryos Obtained From GnRH-agonist Long and GnRH-antagonist Ovarian Stimulation ProtocolStatus unknownNCT01636505Phase 3
- Evaluation of the Luteolytic Effect of a Gonadotropin Releasing Hormone (GnRH) Agonist After the Administration of Human Chorionic Gonadotropin (hCG) in the Initial Follicular Phase a Its Influence on the Prognosis of in Vitro Fertilization TreatmentStatus unknownNCT00948805Phase 3
- Antagonist/Letrozole in Poor RespondersCompletedNCT00823004Phase 1/2
- A Prospective Randomized Phase III Study Comparing Hormonal Therapy +/-DocetaxelStatus unknownNCT00764166Phase 3
- Growth and Metabolic Response to GH and GnRHa Treatment Versus GH Alone in Boys Born SGA.CompletedNCT00522743Not applicable
- Treatment of Endometriosis With Norethindrone Acetate ( NA) VS. Gonadotropin- Releasing Hormone (GnRH) Agonist (Lupron Depot 11.25 mg)Status unknownNCT00458458Phase 3
- Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate CancerCompletedNCT00006359Phase 2